Concepedia

Marit Liland Sandvold

ML

15

Publications

667

Citations

15

H-Index

1985

Active since

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

Clavis Technology (Norway)

Rega Institute for Medical Research

Norwegian Cancer Society

European Organisation for Research and Treatment of Cancer

Marit Liland Sandvold is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, pharmacology, and pathology.

Top concepts

Publications per year

1985–2013

15

Publications

15

Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models

Andries M. Bergman, Auke D. Adema, Jan Balzarini et al. · Investigational New Drugs · 2010 · 94 citations · Full text

Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy

Bodo Brueckner, Maria Rius, Maria Rivera Markelova et al. · Molecular Cancer Therapeutics · 2010 · 85 citations

Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines

Andries M. Bergman, C.M. Kuiper, Daphne Voorn et al. · Biochemical Pharmacology · 2003 · 85 citations · Full text

, , +3

Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.

Knut Breistøl, Jan Balzarini, Marit Liland Sandvold et al. · PubMed · 1999 · 70 citations

, , +13

Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126

Auke D. Adema, Kees Smid, Nienke Losekoot et al. · Investigational New Drugs · 2011 · 51 citations · Full text

Rows per page

1–5 of 15